Business Wire

Seoul Semiconductor Hosts European Symposium on “Human-Centric Lighting & Health”

Del

Seoul Semiconductor, a global innovator of LED products and technology, hosted a symposium featuring academics and industry insiders that focused on scientifically and objectively demonstrating the effects of light on health and circadian rhythm. Held on March 21 in conjunction with Light + Building 2018, the largest lighting exhibition in the world, Seoul Semiconductor’s symposium was entitled “Human-Centric Lighting & Health.”

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180329005388/en/

Scene from the SunLike Series LED Symposium held at the 2018 Light + Building Exhibition in Frankfur ...

Scene from the SunLike Series LED Symposium held at the 2018 Light + Building Exhibition in Frankfurt, Germany. (Photo: Business Wire)

The half-day symposium program consisted of several invited experts, including Professor Russell Foster from the University of Oxford, widely accepted as the leading authority in light, sleep, and circadian rhythm research; along with Dr. Manuel Spitschan from the University of Oxford, and Dr. Octavio L. Perez from Mount Sinai Hospital in New York. All three experts gave presentations on the effects of light on human health, and discussed the future direction of lighting.

According to Professor Foster, “Light not only allows us to perceive space, but also plays a critical role in enabling us to perceive time by controlling our circadian rhythm and sleep. To sustain a healthy and happy life, we must get the best sleep and keep our circadian rhythm at an optimum level. We also need to replace today’s artificial lighting systems that hinder our circadian rhythm with more human-centric lighting.”

In another presentation, Dr. Manuel Spitschan from the University of Oxford emphasized the impact of light on the body’s circadian rhythm, stating, “Light has an extremely significant impact on human eyes and brain, due to the photoreceptors in the retina. These receptors perceive red, green, and blue light, and accept the color spectrum in varying degrees.” Dr. Spitschan added, “In particular, intrinsically photosensitive retinal ganglion cells (ipRGC), deliver signals from light via a direct connection to the brain, and react more sensitively to blue light within a certain wavelength. When these cells are activated, it causes the body to inhibit the production of melatonin, a hormone that regulates sleep, therefore affecting the 24-hour circadian rhythm.”

Addressing the importance of sunlight in next-generation architecture standards, Dr. Octavio Perez from Mount Sinai Hospital in New York explained, “Typically, people who live in buildings with great lighting – in other words, buildings that get a lot of sunlight – are healthier and happier, compared to people living in artificially-lit indoor spaces. This is because artificial light features a spectrum that vastly differs from natural sunlight."

“Artificial light, such as fluorescent light and LEDs that emit a spectrum with irregular light waves, hinder the user’s circadian rhythm and eyesight,” Dr. Perez continued. “In the long term, this exposure to artificial light is known to have a negative impact on the human body. However, the SunLike Series natural spectrum LEDs create light with a spectrum that is close to sunlight, offering significant benefits for eye protection and accurate color reproduction, making it an ideal lighting source for architecture, thus we expect it to become more popular in the field moving forward.”

Dr. Perez also stated, “Development in light fixtures which use natural light sources such as SunLike Series LEDs, will revolutionize future standards and design, as the construction industry applies even stricter standards to provide people with good quality light. As such, companies must focus on developing light fixtures that produce natural light.”

SunLike natural spectrum LED technology, developed by Seoul Semiconductor and Toshiba Materials, was awarded the Gold Award by Elektronik, a prestigious German magazine specializing in electronic components that has the largest number of subscribers in Germany.

Seoul Semiconductor global marketing group executive vice president Caleb Won said, “The researchers who were awarded the Nobel Prize in Physiology in 2017 identified the genes that govern the circadian rhythm, which controls the main functions of human behavior, including the level of hormones, sleeping, body temperature, and metabolism. Their research clearly shows the importance of maintaining the 24-hour cycle circadian rhythm formed by natural sunlight.”

Won continued, “This Symposium presented scientific, objective evidence on the impact of light on our circadian rhythm, sleep, and health. It was a meaningful opportunity to increase attention and awareness on the need for light fixtures that offer natural light, and to contemplate future directions for lighting. The SunLike Series LEDs, which recreate light that closely matches the natural spectrum of sunlight, promises to be the next-generation light source to lead the era of human-centric lighting.”

About TRI-R technology

TRI-R is a registered trademark of Toshiba Material Co., Ltd. It is a natural light LED light source technology that reproduces the spectrum of natural sunlight, developed by the concept and spectrum technology of natural light.

About Seoul Semiconductor:

Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity, cost savings at the fixture level with high lumen density and allows design flexibility; NanoDriver Series – the world’s smallest 24W DC LED Drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, includes all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC.

For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com

# Trademarks

WICOP and Acrich are trademarks of Seoul Semiconductor Co., Ltd.

Contact information

Europe
Seoul Semiconductor Europe GmbH
Ariane Heim
Tel: +49 (0)89 450 3690-0
Email: press.eu@seoulsemicon.com
or
North America
Seoul Semiconductor Inc.
Andrew Smith
Tel: +1 (901) 831-6614
Email: andrew.smith@seoulsemicon.com
or
Asia
Seoul Semiconductor Co., Ltd
Jake Jung
Tel: +82 070.4391.8270
Email: pr@seoulsemicon.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

PSE: APM Forum 2018 Focus on Digitalisation for the Process Industries20.4.2018 15:13Pressemelding

At the 2018 Advanced Process Modelling (APM) Forum this week, process industry organisations presented on digital design and operations applications ranging from accelerating development of the next generation of pharmaceuticals to realising millions of dollars per year in increased profit for large process plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005517/en/ Ben Weinstein, head of R&D Product and Process Systems Modeling at Procter & Gamble, delivers the keynote speech on how digital design techniques are used systematically to accelerate innovation in P&G. (Photo: Business Wire) Introducing the conference, Prof. Costas Pantelides, MD of conference host Process Systems Enterprise (PSE), described the current wave of digitalisation as the culmination of many years of advanced modelling and IT development. “This is a time of extraordinary opportunities for the process industries” he said. Keynote speaker Ma

Aperta Provides Electronic Funds Transfer (EFT) in Cayman Islands20.4.2018 14:01Pressemelding

Once again, the Aperta Active Clearing System (ACS) has delivered the mechanism for a country to implement a world-class electronic payment processing environment to maximize a national payments system’s efficiency, effectiveness, security and control. Aperta partnered with the Cayman Islands ACH Operator (Prism Services (Cayman) Ltd.) and local commercial banks to deliver a new Electronic Funds Transfer system. The old process of banks swapping files in a wide-variety of standards and settling bilaterally has been replaced with a common system and standards, employing international-standard secure file transfer protocol, allowing participants to monitor real time net settlement and collateral positions via a secure portal. The Cayman Islands Automated Clearinghouse (CIACH) links all six of the country’s banks and provides the central clearing and settlement mechanism for banks to exchange direct debit and direct credit transactions seamlessly across the country. It is functionally NAC

FII Tech Growth Invests in SECO20.4.2018 13:39Pressemelding

FII Tech Growth, a fund managed by Fondo Italiano d’Investimento SGR, announces today its second investment in SECO SpA, one of the European leaders in the embedded electronics market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005413/en/ (Photo: SECO) SECO, headquartered in Arezzo, Tuscany, with subsidiaries in the U.S.A., Germany and Taiwan, was founded in 1979 by entrepreneurs Daniele Conti and Luciano Secciani. The company designs and manufactures micro-computers and integrated systems for industrial applications. With more than 250 employees, SECO supports customers with a worldwide presence such as Cimbali, Esaote, Technogym and Vimar, and generated revenue in excess of Euro 50 million in 2017. The ability to offer innovative solutions by using cutting-edge technologies has allowed SECO to grow steadily over time. The company developed a network of collaborations with universities and research centres La Sapi

Schlumberger Announces First-Quarter 2018 Results20.4.2018 11:05Pressemelding

Schlumberger Limited (NYSE:SLB) today reported results for the first quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31, 2018 Dec. 31, 2017 Mar. 31, 2017 Sequential Year-on-year Revenue $7,829 $8,179 $6,894 -4% 14% Pretax operating income $974 $1,155 $757 -16% 29% Pretax operating margin 12.4% 14.1% 11.0% -169 bps 145 bps Net income (loss) - GAAP basis $525 $(2,255) $279 n/m 88% Net income, excluding charges & credits* $525 $668 $347 -21% 51% Diluted EPS (loss per share) - GAAP basis $0.38 $(1.63) $0.20 n/m 90% Diluted EPS, excluding charges & credits* $0.38 $0.48 $0.25 -21% 52% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. n/m = not meaningful Schlumberger Chairman and CEO Paal Kibsgaard commented, “As forecast, our results in the first quarter of 2018 largely reflected transitory factors, with seasonal reductions in activity in the Northern Hemisphere and planned project startup costs

Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases20.4.2018 10:30Pressemelding

Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogen’s expertise in neuroscience research and drug development and Ionis’ leadership in RNA targeted therapies with the goal of developing a broad pipeline of investigational therapies. It builds upon a productive collaboration that produced SPINRAZA, the first and only approved treatment for patients with spinal muscular atrophy. Today, April 20, 2018, Biogen and Ionis will host company conference calls and webcasts to discuss the new collaboration. Full webcast details can be found below. Under the terms of the collaboration, Biogen will pay Ionis $1 billion in cash, which will include $625 million to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, at an appr

Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 20:37Pressemelding

Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f